Japan vs Middle income: Cause of death, by non-communicable diseases, ages 5-14
Japan
61.0%
in 2021
Middle income
25.5%
in 2021
Japan rank
30th
Middle income rank
28th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Japan
- Middle income
How they compare
Japan currently reports 61.0% against 25.5% in Middle income, a difference of 35.5%.
That makes Japan's figure about 2.4 times Middle income's.
Across all 6 years both countries report, Japan has been ahead every year.
Japan ranks 30th and Middle income ranks 28th of 185 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Japan | Middle income | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.4% | 18.0% | 34.5% | Japan |
| 2010s | 58.2% | 22.5% | 35.6% | Japan |
| 2020s | 59.0% | 25.5% | 33.5% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Japan or Middle income?
- Japan, at 61.0% against 25.5% in Middle income as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Japan and Middle income?
- 35.5%, with Japan ahead.
- How many years of comparable data are there for Japan and Middle income?
- 6 years are reported by both, from 2000 to 2021.
- How do Japan and Middle income rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Japan ranks 30th and Middle income ranks 28th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.